Diseases & Disorders
(G300)
IRS Verified
DX Registered
990 on File
AMERICAN CANCER SOCIETY INC
Financial strength (30%)
72/100
Reliability (20%)
70/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
The mission of the American Cancer Society is to improve the lives of people with cancer and their families through advocacy, research, and patient support, to ensure everyone has an opportunity to prevent, detect, treat, and survive cancer.
Financial Overview — FY 2025
$136.8M
Total Revenue
$166.6M
Total Expenses
$1233.4M
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
77.0%
Fundraising Efficiency
458.1%
Operating Reserve
88.82x
Liability-to-Asset
25.4%
Revenue Diversification
90.4%
Executive Compensation
$665K
Compared with Peers
FY 2025
Compared with 21 similar organizations
(United States, Diseases & Disorders, $100M and over in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
77.0% | 83.9% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
4.9% | 8.8% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
18.1% | 0.8% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
458.1% | 512.7% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
88.8 mo | 8.2 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
25.4% | 31.3% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
90.4% | 94.4% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
-81.1% | 8.2% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-79.0% | 7.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-21.8% | 0.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $136.8M | $166.6M | $1233.4M | 77.0% | 0 |
| 2024 | $724.2M | $791.9M | $1295.9M | 79.8% | 3348 |
| 2023 | $656.8M | $756.3M | $1278.4M | 79.4% | 3300 |
| 2022 | $674.5M | $669.2M | $1255.2M | 81.1% | 3153 |
| 2021 | $734.4M | $577.7M | N/A | — | 2940 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.